Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 9;57(4):368.
doi: 10.3390/medicina57040368.

Is Early Surgical Treatment for Benign Prostatic Hyperplasia Preferable to Prolonged Medical Therapy: Pros and Cons

Cora Fogaing  1 , Ali Alsulihem  2 , Lysanne Campeau  1 , Jacques Corcos  1
Affiliations
Review

Is Early Surgical Treatment for Benign Prostatic Hyperplasia Preferable to Prolonged Medical Therapy: Pros and Cons

Cora Fogaing et al. Medicina (Kaunas). .

Abstract

Background and objectives: Treatment of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH) has shifted over the last decades, with medical therapy becoming the primary treatment modality while surgery is being reserved mostly to patients who are not responding to medical treatment or presenting with complications from BPH. Here, we aim to explore the evidence supporting or not early surgical treatment of BPH as opposed to prolonged medical therapy course. Materials and Methods: The debate was presented with a "pro and con" structure. The "pro" side supported the early surgical management of BPH. The "con" side successively refuted the "pro" side arguments. Results: The "pro" side highlighted the superior efficacy and cost-effectiveness of surgery over medical treatment for BPH, as well as the possibility of worse postoperative outcomes for delayed surgical treatment. The "con" side considered that medical therapy is efficient in well selected patients and can avoid the serious risks inherent to surgical treatment of BPH including important sexual side effects. Conclusions: Randomized clinical trials comparing the outcomes for prolonged medical therapy versus early surgical treatment could determine which approach is more beneficial in the long-term in context of the aging population. Until then, both approaches have their advantages and patients should be involve in the treatment decision.

Keywords: 5 alpha-reductase inhibitor; Holep; alpha-adrenoceptor antagonist; alpha-blocker; benign prostatic hyperplasia; complications; green light; laser; lower urinary tract symptoms; transurethral resection of the prostate.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. McConnell J.D., Roehrborn C.G., Bautista O.M., Andriole G.L., Jr., Dixon C.M., Kusek J.W., Lepor H., McVary K.T., Nyberg L.M., Jr., Clarke H.S., et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N. Engl. J. Med. 2003;349:2387–2398. doi: 10.1056/NEJMoa030656. - DOI - PubMed
    1. Roehrborn C.G., Siami P., Barkin J., Damiao R., Major-Walker K., Nandy I., Morrill B.B., Gagnier R.P., Montorsi F., Comb A.T.S.G. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur. Urol. 2010;57:123–131. doi: 10.1016/j.eururo.2009.09.035. - DOI - PubMed
    1. Roehrborn C.G., Barkin J., Siami P., Tubaro A., Wilson T.H., Morrill B.B., Gagnier R.P. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. BJU Int. 2011;107:946–954. - PubMed
    1. Vela-Navarrete R., Gonzalez-Enguita C., Garcia-Cardoso J.V., Manzarbeitia F., Sarasa-Corral J.L., Granizo J.J. The impact of medical therapy on surgery for benign prostatic hyperplasia: A study comparing changes in a decade (1992-2002) BJU Int. 2005;96:1045–1048. doi: 10.1111/j.1464-410X.2005.05735.x. - DOI - PubMed
    1. Marszalek M., Ponholzer A., Pusman M., Berger I., Madersbacher S. Transurethral Resection of the Prostate. Eur. Urol. Suppl. 2009;8:504–512. doi: 10.1016/j.eursup.2009.02.003. - DOI

LinkOut - more resources